Orchard nears FDA decision on rare disease gene therapy

Submitted by admin on September 18, 2023 - 12:25pm

Source:

BioPharma Dive

News Tags:

Orchard Therapeutics

gene therapy

metachromatic leukodystrophy

FDA

Headline:

Orchard nears FDA decision on rare disease gene therapy

snippet:

The Food and Drug Administration is reviewing Orchard Therapeutics’ approval application for a gene therapy to treat the rare disease metachromatic leukodystrophy, setting a decision deadline of March 18, 2024, the company said Monday.

Search form

You are here

Orchard nears FDA decision on rare disease gene therapy

Orchard nears FDA decision on rare disease gene therapy